Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Cash (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Change in Cash data on record, last reported at $1.3 million in Q1 2013.

  • For Q1 2013, Change in Cash rose 180.87% year-over-year to $1.3 million; the TTM value through Mar 2013 reached $4.5 million, up 545.98%, while the annual FY2025 figure was $2.2 million, 424.57% up from the prior year.
  • Change in Cash reached $1.3 million in Q1 2013 per SNOA's latest filing, up from -$1.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $3.9 million in Q3 2012 and bottomed at -$1.7 million in Q4 2012.
  • Average Change in Cash over 4 years is $136833.3, with a median of $53500.0 recorded in 2010.
  • The widest YoY moves for Change in Cash: up 378.76% in 2012, down 433.11% in 2012.
  • A 4-year view of Change in Cash shows it stood at -$694000.0 in 2010, then soared by 292.94% to $1.3 million in 2011, then plummeted by 227.86% to -$1.7 million in 2012, then skyrocketed by 176.05% to $1.3 million in 2013.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $1.3 million in Q1 2013, -$1.7 million in Q4 2012, and $3.9 million in Q3 2012.